Skip to main content
. Author manuscript; available in PMC: 2019 Nov 5.
Published in final edited form as: Mol Pharm. 2018 Sep 28;15(11):5162–5173. doi: 10.1021/acs.molpharmaceut.8b00717

Fig. 6.

Fig. 6.

Biodistribution of different PTX and Sun formulations in 4T1.2 tumor-bearing mice. Tissue and organs were harvested 24 h after i.v. administration of (A) Taxol, PTX/PEG5K-Fmoc-NLG2 mixed micelles or PTX+Sun/PEG5K-Fmoc-NLG2 mixed micelles at a PTX dose of 10 mg kg−1 or (B) Sun, Sun/PEG5K-Fmoc-NLG2 mixed micelles or PTX+Sun/PEG5K-Fmoc-NLG2 at a Sun dose of 10 mg kg−1. PTX and Sun concentrations were measured by HPLC-MS. *P<0.05 (vs control, N=3).